Style | Citing Format |
---|---|
MLA | Khorsandi K, et al.. "Nano Antiviral Photodynamic Therapy: A Probable Biophysicochemical Management Modality in Sars-Cov-2." Expert Opinion on Drug Delivery, vol. 18, no. 2, 2021, pp. 265-272. |
APA | Khorsandi K, Fekrazad S, Vahdatinia F, Farmany A, Fekrazad R (2021). Nano Antiviral Photodynamic Therapy: A Probable Biophysicochemical Management Modality in Sars-Cov-2. Expert Opinion on Drug Delivery, 18(2), 265-272. |
Chicago | Khorsandi K, Fekrazad S, Vahdatinia F, Farmany A, Fekrazad R. "Nano Antiviral Photodynamic Therapy: A Probable Biophysicochemical Management Modality in Sars-Cov-2." Expert Opinion on Drug Delivery 18, no. 2 (2021): 265-272. |
Harvard | Khorsandi K et al. (2021) 'Nano Antiviral Photodynamic Therapy: A Probable Biophysicochemical Management Modality in Sars-Cov-2', Expert Opinion on Drug Delivery, 18(2), pp. 265-272. |
Vancouver | Khorsandi K, Fekrazad S, Vahdatinia F, Farmany A, Fekrazad R. Nano Antiviral Photodynamic Therapy: A Probable Biophysicochemical Management Modality in Sars-Cov-2. Expert Opinion on Drug Delivery. 2021;18(2):265-272. |
BibTex | @article{ author = {Khorsandi K and Fekrazad S and Vahdatinia F and Farmany A and Fekrazad R}, title = {Nano Antiviral Photodynamic Therapy: A Probable Biophysicochemical Management Modality in Sars-Cov-2}, journal = {Expert Opinion on Drug Delivery}, volume = {18}, number = {2}, pages = {265-272}, year = {2021} } |
RIS | TY - JOUR AU - Khorsandi K AU - Fekrazad S AU - Vahdatinia F AU - Farmany A AU - Fekrazad R TI - Nano Antiviral Photodynamic Therapy: A Probable Biophysicochemical Management Modality in Sars-Cov-2 JO - Expert Opinion on Drug Delivery VL - 18 IS - 2 SP - 265 EP - 272 PY - 2021 ER - |